ABSTRACT
Background and aims
Cigarette smoking often results in nicotine dependence. With use of electronic cigarettes as an alternative source of nicotine, it is important to assess dependence associated with e‐cigarette use. This study assesses dependence among current and former adult e‐cigarette users on cigarettes and e‐cigarettes, compared with dependence on cigarettes.
Design
Cross‐sectional data from the Population Assessment of Tobacco and Health (PATH) study from 2013–2016. Psychometrically assessed dependence was compared for cigarettes and e‐cigarettes among current and former exclusive and dual users of the products and among e‐cigarette users who had and had not recently stopped smoking.
Setting
A population‐based representative sample of US adults.
Participants
Participants were 13 311 US adults (18+) in Waves 1–3 of PATH reporting current established smoking, current use of e‐cigarettes, or stopping use of either product in the past year who were administered dependence assessments for cigarettes and/or e‐cigarettes.
Measurements
A 16‐item scale assessing tobacco dependence (on a 1–5 scale), previously validated for assessment and comparison of dependence on varied tobacco products, including cigarettes and e‐cigarettes, with a variation assessing residual dependence among users who stopped in the past year.
Findings
Among current users, dependence on e‐cigarettes was significantly lower than dependence on cigarettes, in within‐subjects comparisons among dual users of both e‐cigarettes and cigarettes (1.58 [SE = 0.05] vs. 2.76 [0.04]), P < 0.0001), and in separate groups of e‐cigarette users and cigarette smokers (1.95 [0.05] vs. 2.52 [0.02], P < 0.0001), and among both daily and non‐daily users of each product. Among former users, residual symptoms were significantly lower for e‐cigarettes than cigarettes, both among former dual users (1.23 [0.07] vs. 1.41 [0.06], P < 0.001) and among users of one product (1.28 [0.03] vs. 1.53 [0.03], P < 0.0001). The highest level of e‐cigarette dependence was among e‐cigarette users who had stopped smoking (2.17 [0.08]). Conclusion
Use of e‐cigarettes appears to be consistently associated with lower nicotine dependence than cigarette smoking.
Keywords: Cigarettes, dependence, electronic cigarettes, nicotine, tobacco, youth use
INTRODUCTION
Electronic cigarettes (e‐cigarettes) were introduced into the United States (US) ~10 years ago, and their use has increased since then, with 2.8% of adults reporting past‐30‐day use of e‐cigarettes [1]. There is broad agreement that e‐cigarettes pose less risk than cigarette smoking [2, 3], and thus may have potential for harm reduction, but some have expressed concern about their potential to cause or perpetuate nicotine dependence [4]. Studies suggest that e‐cigarettes are associated with less dependence than tobacco cigarettes [5, 6] (although see [7]). However, these studies were based on unrepresentative samples (eg, recruited via online vaping or smoking cessation forums; college students), and used measures that had not been validated for comparing degree of dependence between e‐cigarettes and conventional cigarettes. One scale was tested for this purpose, with similar results, but on a small sample of dual users from an opt‐in consumer panel [8].
The Population Assessment of Tobacco and Health (PATH) study, a large survey of a representative sample of the US adult population, enables population‐based comparisons of dependence on cigarettes and e‐cigarettes. PATH's dependence scale was largely drawn from the Wisconsin Inventory of Smoking Dependence Motives (WISDM) [9] and the Nicotine Dependence Syndrome Scale (NDSS) [10], which have been extensively validated for assessing dependence in smokers, demonstrating relationships to other dependence scales, self‐rated addiction, cigarette consumption, laboratory self‐administration, persistence or progression of use, craving, withdrawal, and relapse [11, 12, 13, 14, 15, 16, 17]. WISDM items have also been validated in e‐cigarette users [14]. An additional item was drawn from the Diagnostic and Statistical Manual of Mental Disorders (DSM‐V) criteria [18], closely mirroring an item from the Fagerstrom test for Nicotine Dependence, each of which also has evidence of validity [19, 20]. Respondents completed the scale for cigarette smoking and, separately, for e‐cigarette use (Table S1). Strong et al. [21] applied item response theory (IRT) methods [22] to develop a unidimensional scale that was statistically demonstrated to yield a common metric for both smoking and e‐cigarette use; analyses showed no differential item functioning between the cigarette scales and the e‐cigarette scales, allowing for like‐for‐like comparison of scores between products. Strong et al. [21] showed that the scale reliably differentiated daily versus non‐daily users both for cigarettes and e‐cigarettes. A variation of the items, worded to focus on post‐quit experiences, assessed residual symptoms of dependence (Table S2) among people who quit cigarettes or e‐cigarettes during the past year, as important symptoms of dependence may appear or persist after quitting.
Strong et al.’s [21] analysis of PATH Wave 1 data suggested that e‐cigarettes produced less dependence than cigarette smoking. We extend those findings to a larger sample encompassing three PATH waves, and also distinguish different groups of users to address several questions:
How do residual symptoms of dependence differ between recent quitters of cigarettes and/or e‐cigarettes?
What degree of e‐cigarette dependence is seen among former smokers who have switched completely to e‐cigarettes, who may have shifted their nicotine dependence from cigarettes to e‐cigarettes?
METHODS
PATH is a nationally representative survey of tobacco use with annual waves of data collection with a four‐stage, stratified probability sample of noninstitutionalized, civilian US adults (approved by the Westat Institutional Review Board) [25]. Adults (ages 18+) were screened in person. African Americans, young adults aged 18–24, and tobacco users were oversampled. Data were collected at respondents' homes using computer‐assisted self‐report (in English or Spanish) [26].
Our analyses include the first three waves of the PATH data (Wave 1 September 2013 to December 2014; Wave 2 October 2014 to October 2015; and Wave 3 October 2015 to October 2016). Among screened households, the weighted wave 1 response rate was 74.0% (n = 32 320). Among eligible participants, the weighted response rate for wave 2 was 83.2% (n = 28 362), and wave 3 was 78.4% (n = 28 148).
Study population
The analyses, based on public use datasets [27], included n = 13 311 adult respondents. Table 1 defines the subgroups used in analyses.
Table 1.
Category | Definition |
---|---|
Current established smoker a | Smoked >100 cigarettes lifetime AND now smokes every day or some days |
Current established e‐cigarette user b | Ever used e‐cigarettes “fairly regularly” AND now uses them every day or some days |
Current dual user | Meets both above definitions |
Former user | Was an established user AND stopped using in the past year |
Former dual user | Meets Former User definition for both cigarettes and e‐cigarettes |
Daily smoker/user | Reports smoking/using at least 27 days in past 30 days |
Non‐daily smokers/user | Reports smoking/using less than 27 days in past 30 days |
Could not be using any other tobacco products (e‐cigarettes excluded).
This was further stratified (Tables S3–S5) by separating those who did and did not indicate currently using other tobacco products (traditional cigars, cigarillos, filtered cigars, pipe tobacco, hookah, smokeless tobacco, snus, and dissolvable tobacco); those indicating dual use of e‐cigarettes and cigarettes are reported under dual user.
Measures
The PATH dependence scale [21] consists of 16 items (15 using a 1–5 scale ranging from “not at all true of me” to “extremely true of me”; one dichotomous item was scored 1 or 5) (Table S1). Items were presented in random order. Following Strong et al. [21], we scored the dependence measure by averaging the relevant items.
The PATH algorithm for administering the dependence items was complex [26]. All established users of e‐cigarettes were administered the e‐cigarette items (analyses did not distinguish among types of e‐cigarettes, because the user base for some types was small, and the distinctions were not consistently made across waves of PATH data). Established cigarette smokers were administered the items about cigarettes only if they did not also use another form of tobacco (other than e‐cigarettes); poly‐tobacco‐users were administered the items with respect to their “tobacco use” in aggregate, which is difficult to interpret and does not specifically assess cigarette dependence. Thus, the cigarette dependence measure analyses focus on established cigarette smokers who did not also use another form of tobacco (e‐cigarettes excluded). The e‐cigarette dependence measure was assessed on all current users of e‐cigarettes. (Table S3 shows that differences between those who did and did not use other products were small, and below the threshold for meaningful differences. Thus, the focus of e‐cigarette dependence measure analyses remained on users.) Dual users of both e‐cigarettes and cigarettes were administered the items separately for each product (in that order), allowing within‐subject comparisons of dependence scores. Additionally, individuals who stopped using e‐cigarettes or cigarettes, respectively, in the past year were administered variant items referring to their current residual dependence‐related experiences (e.g., “I still have urges to [smoke cigarettes]|[use e‐cigarettes]”; see Table S2).
PATH respondents reported demographic data. Current smokers and e‐cigarette users were asked how many days per month they smoked/used e‐cigarettes. Smokers reported cigarettes per day. Although PATH asked about quantity of consumption for e‐cigarettes, the data did not allow for aggregation, or comparison to cigarettes consumption (see Supplement 1). The public‐use PATH data also did not allow for detailed computation of duration of use, though it was possible to assess this crudely in a subset of smokers (see Supplement 2).
Statistical analysis
Analyses compared dependence on cigarettes to dependence on e‐cigarettes, both among dual users, who were assessed for both products, allowing for within‐subject comparisons, and between exclusive smokers and exclusive e‐cigarette users, providing between‐subject comparisons. Because daily use has a substantial influence on dependence [21, 28], and is more common for smoking than for e‐cigarette use [29], to compare like with like, we also compared subsets who were either daily users of both or non‐daily users of both. Analyses also compared residual dependence among former smokers and former e‐cigarette users, both within‐subjects (former users of both) and between subjects (former users of one or the other), and among those who stopped using both. PATH data did not distinguish daily use prior to quitting. Finally, analyses compared dependence on e‐cigarettes among current users who had quit smoking, compared to those who were currently also smoking.
Analyses used generalized linear models that account for the inclusion of multiple observations from some respondents (PROC GENMOD, with a REPEATED statement, SAS version 9.4), and were weighted per PATH methodology [26] to generate nationally representative estimates. Our primary analyses adjusted for age, sex, ethnicity, and education, and PATH wave; unadjusted analyses are shown in Table S5. These analyses were not pre‐registered on a publicly available platform, so should be considered exploratory.
RESULTS
Table 2 shows the sample sizes and descriptive characteristics of the samples included in the analyses.
Table 2.
Established smokers a only | Established e‐cigarette users b | Established dual users of e‐cigarettes and cigarettes | Past year former smokers only | Past year former users of e‐cigarette only | Past year former dual users of e‐cigarettes and cigarettes | |
---|---|---|---|---|---|---|
n c = | 9838 | 2337 | 1282 | 2166 | 1747 | 175 |
k d = | 19 257 | 3422 | 1673 | 2487 | 2039 | 181 |
Age (y) e | ||||||
18–24 | 1609 (10.4) | 1043 (32.9) | 224 (11.7) | 421 (11.3) | 700 (29.7) | 47 (21.4) |
25–34 | 2193 (22.6) | 538 (28.6) | 316 (25.9) | 617 (27.2) | 453 (29.2) | 56 (31.5) |
35–44 | 1804 (19.4) | 315 (15.3) | 287 (24.3) | 402 (20.0) | 252 (17.3) | 29 (18.5) |
45–54 | 1955 (21.1) | 220 (10.9) | 222 (18.1) | 306 (16.5) | 174 (11.6) | 18 (11.4) |
55–64 | 1521 (17.3) | 160 (8.5) | 171 (14.0) | 271 (15.4) | 113 (8.1) | 20 (12.1) |
65–74 | 596 (7.0) | 51 (3.2) | 56 (5.3) | 117 (7.4) | 46 (3.5) | 4 (4.3) |
75+ | 158 (2.2) | 10 (0.6) | 6 (0.6) | 32 (2.3) | 9 (0.7) | 1 (0.9) |
Sex | ||||||
Male | 4564 (49.9) | 1420 (63.2) | 530 (45.3) | 930 (44.1) | 946 (57.1) | 77 (49.3) |
Female | 5270 (50.1) | 916 (36.8) | 752 (54.7) | 1233 (55.9) | 801 (42.9) | 98 (50.7) |
Ethnicity | ||||||
Non‐Hispanic Caucasian | 6404 (67.6) | 1553 (70.5) | 1006 (81.4) | 1432 (69.5) | 1180 (72.9) | 130 (78.2) |
Non‐Hispanic African American | 1395 (13.9) | 207 (9.2) | 78 (6.4) | 206 (9.4) | 147 (8.2) | 13 (6.0) |
Hispanic | 1337 (12.7) | 364 (12.5) | 106 (6.6) | 354 (15.0) | 255 (11.9) | 20 (9.4) |
Non‐Hispanic other | 677 (5.7) | 209 (7.8) | 91 (5.6) | 168 (6.0) | 160 (7.0) | 11 (6.3) |
Education | ||||||
< High school | 1786 (17.4) | 305 (11.2) | 165 (11.9) | 232 (10.3) | 238 (12.5) | 12 (6.4) |
High school graduate/GED | 3607 (39.1) | 834 (36.2) | 407 (32.4) | 617 (31.8) | 557 (30.5) | 39 (22.9) |
Some college/Associates degree | 3314 (31.9) | 930 (40.8) | 547 (42.0) | 853 (34.2) | 769 (45.5) | 88 (49.5) |
College degree or more | 1061 (11.6) | 243 (11.9) | 159 (13.7) | 461 (23.7) | 176 (11.5) | 35 (21.2) |
Cigarettes per day | ||||||
Mean (SE) | 12.41 (0.14) | N/A | 11.32 (0.29) | N/A | N/A | N/A |
Cigarette days per month | ||||||
Mean (SE) | 25.92 (0.12) | N/A | 24.55 (0.35) | N/A | N/A | N/A |
E‐cigarette days per month | ||||||
Mean (SE) | N/A | 18.19 (0.29) | 15.20 (0.46) | N/A | N/A | N/A |
Due to repeated waves, only demographic characteristics from the first year a respondent was in a given category are included in this table.
Who did not currently use another form of tobacco.
Due to PATH methodology, all current established e‐cigarette users were administered the e‐cigarette dependence items, even if they used other tobacco products; this group is limited to those not currently smoking cigarettes.
Number of respondents.
Number of observations; some respondents have multiple observations due to the inclusion of three waves of data.
Numbers are unweighted; percentages are weighted.
Analyses of the PATH dependence scales
The dependence scores for both cigarettes and e‐cigarettes covered the full range from 1 to 5, and had very high reliability (Cronbach's α ≥0.95) for both cigarette and e‐cigarette assessments, and were systematically related to other measures of dependence, such as time to first use, self‐perceived addiction, and craving (Supplement 3). Evidence suggested that differences of ~0.40 or more were meaningful (Supplement 4).
Current established users
Table 3 shows the mean dependence scores for the various groups analyzed.
Table 3.
Current users | Adjusted analysis a | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cigarette dependence | E‐cigarette dependence | ||||||||||
n | k | Mean | SE | n | k | Mean | SE | M CIG ‐M ECIG | 95% CI | p b | |
Current non‐dual users | 9768 | 19 089 | 2.52 | 0.02 | 2310 | 3382 | 1.95 | 0.05 | 0.56 | 0.51,0.62 | <0.001 |
Daily cigarettes or e‐cigarettes | 8271 | 15 927 | 2.81 | 0.02 | 1149 | 1671 | 2.22 | 0.07 | 0.58 | 0.51,0.65 | <0.001 |
Non‐daily cigarettes or e‐cigarettes | 2310 | 3133 | 1.64 | 0.03 | 1374 | 1694 | 1.56 | 0.06 | 0.08 | 0.02,0.15 | <0.001 |
Current dual users (within‐subjects) | 1277 | 1664 | 2.76 | 0.04 | 1277 | 1664 | 1.58 | 0.05 | 1.18 | 1.07,1.30 | <0.001 |
Both cigarettes and e‐cigarettes daily | 321 | 364 | 2.94 | 0.12 | 321 | 364 | 1.81 | 0.09 | 1.13 | 0.90,1.36 | <0.001 |
Both cigarettes and e‐cigarettes non‐daily | 155 | 164 | 2.14 | 0.09 | 155 | 164 | 1.38 | 0.08 | 0.76 | 0.51,1.01 | <0.001 |
Former users | |||||||||||
Former non‐dual users | 2155 | 2474 | 1.53 | 0.03 | 1735 | 2022 | 1.28 | 0.03 | 0.25 | 0.20,0.31 | <0.001 |
Former non‐dual users, quit in past 6 months | 1587 | 1779 | 1.61 | 0.04 | 1269 | 1429 | 1.33 | 0.04 | 0.28 | 0.22,0.34 | <0.001 |
Former non‐dual users, quit in past 3 months | 1151 | 1258 | 1.71 | 0.05 | 870 | 959 | 1.42 | 0.06 | 0.29 | 0.20,0.37 | <0.001 |
Former dual users (within‐subjects) | 173 | 179 | 1.41 | 0.06 | 173 | 179 | 1.23 | 0.07 | 0.19 | 0.02,0.35 | <0.001 |
Current e‐cigarette users, smokers vs. former smokers | E‐cigarette dependence: stopped smoking c | E‐cigarette dependence: smoking | |||||||||
Current e‐cigarette users d | 428 | 465 | 2.17 | 0.08 | 1277 | 1664 | 1.58 | 0.05 | 0.59 | 0.47,0.72 | <0.001 |
Daily e‐cigarette use | 364 | 399 | 2.31 | 0.10 | 532 | 628 | 1.92 | 0.08 | 0.39 | 0.25,0.53 | <0.001 |
Non‐daily e‐cigarette use | 64 | 65 | 1.14 | 0.05 | 854 | 1029 | 1.24 | 0.03 | −0.11 | −0.20,−0.01 | <0.036 |
Adjusted analyses control for PATH wave of data collection, age, sex, ethnicity, and education; unadjusted analyses are shown in Table S1.
With Bonferroni correction for 13 tests, all P‐values except the last one in the table are still P < 0.001; the last is P = 0.47.
Quit in past 12 months.
Stratified by smoking status: former smoker versus current smoker; never smokers not assessed in this analysis.
In within‐subject comparisons among current established users of both cigarettes and e‐cigarettes (dual users), dependence was significantly lower on e‐cigarettes compared to cigarettes. As shown in Fig. S1, these mean differences reflect large differences in the distribution of scores. Whereas 48% of the scores for cigarette smoking were above 3.0, the mid‐point of the scale, this was true for only 8% of e‐cigarette scores. The majority of e‐cigarette dependence scores (64%) were 1.5 or less, suggesting denial of dependence symptoms, a range seen in <13% of the cigarette‐dependence scores. Dependence on e‐cigarettes was also lower than dependence on smoking among daily users of each product, and among non‐daily users of each (Table 3).
A between‐subjects analysis among individuals who either smoked cigarettes or used e‐cigarettes, but not both, showed the same pattern: dependence was lower among e‐cigarette users. Again, this reflected large differences in the distribution of scores, with half the e‐cigarette users scoring ≤1.5 on the 1–5 scale, compared to 17% for cigarette smokers (Fig. S2). Scores for e‐cigarette dependence were lower than those for cigarette dependence both for daily and non‐daily users (Table 3).
Former users
Among former established users of both cigarettes and e‐cigarettes who stopped both in the past year (i.e., former dual users), within‐person comparison showed that residual dependence was significantly lower on e‐cigarettes (Table 3).
A similar pattern was seen in between‐person comparison of former e‐cigarette users and former smokers who were not former dual users. The differences were similar, and slightly larger when the analysis was limited to those who had stopped the respective products within the past 6 months or 3 months. As expected, residual dependence scores trended higher among more recent quitters.
E‐cigarette dependence among current versus former smokers
Among the groups examined, the highest level of e‐cigarette dependence was reported by current e‐cigarette users who had been established cigarette smokers but who had quit smoking in the past year. Their rated dependence on e‐cigarettes was higher than that reported among e‐cigarette users who were still smoking. (Results were similar for those who had quit within the past 6 months or 3 months; data not shown.) However, their e‐cigarette dependence was significantly lower than the cigarette dependence of current smokers, whether the smokers currently used e‐cigarettes, had quit e‐cigarettes (data not shown), or never used e‐cigarettes. The pattern that e‐cigarette dependence was higher among those who had stopped smoking cigarettes held for daily e‐cigarette users, but was reversed for non‐daily e‐cigarette users, where those who were still smoking showed higher (but still low) e‐cigarette dependence.
DISCUSSION
The PATH data for the first time allows direct comparison of dependence on cigarettes and on e‐cigarettes on the same metric in a large representative population sample. The present analyses compared dependence on cigarettes and dependence on e‐cigarettes across a variety of populations varying by current and historical product use. In every comparison, e‐cigarette use was associated with significantly less dependence than cigarette smoking. This applied both to within‐subject comparisons among the individuals who were currently using both products, as well as to between‐person comparisons of individuals who were using one or the other. The differences were substantial, as seen in the distribution of scores: although few e‐cigarette users scored as highly dependent on e‐cigarettes, most smokers were highly dependent on cigarettes. The mean differences observed among current users, though numerically small, were deemed meaningful (see Supplement 4), with the exception of scores among non‐daily users, where even the cigarette smokers obtained very low scores near the scale's floor, indicating denial of dependence, making observation of meaningful declines difficult. E‐cigarette dependence was also lower than cigarette dependence among those who recently stopped using each product, but even the former smokers indicated little or no residual dependence, again making it difficult to observe larger differences. Most striking is the consistency of the findings across multiple subpopulations of users, whether stratified by daily versus non‐daily use, or by current or former usage, and whether analyzed within‐persons or between persons. In every case, dependence was significantly lower on e‐cigarettes than on cigarettes, usually meaningfully so.
Interestingly, among e‐cigarette users, the highest rated e‐cigarette dependence was seen among the e‐cigarette users who had recently quit smoking, especially among those using e‐cigarettes daily. This is consistent with the idea that smokers might transition to exclusive e‐cigarette use by transferring their dependence to e‐cigarettes instead. It could also be due to the fact that stopping smoking completely and transitioning to e‐cigarettes is most likely when e‐cigarettes are used more regularly and in greater amounts [30, 31], which might be associated with greater dependence. This is consistent with the observation that the daily e‐cigarette users show higher e‐cigarette dependence when they have quit smoking. In any case, even in this group, who had transitioned from smoking to e‐cigarettes, dependence on e‐cigarettes was less severe than dependence on cigarettes among continuing daily smokers.
Although not a focus of our analyses, the data also show that e‐cigarette use tends to occur among smokers who show more cigarette dependence. Although the data are cross‐sectional, they suggest one factor that may influence uptake of e‐cigarettes.
Altogether, the data suggest that some dependence on e‐cigarettes does occur, which is not surprising for devices that deliver nicotine. Health authorities have pointed out that it is not nicotine or nicotine dependence, per se, that causes the vast harms of cigarette smoking, but rather the exposure to toxins in cigarette smoke [2, 3, 32, 33]. Indeed, harm reduction advocates have argued that, from a harm reduction perspective, some degree of dependence potential may even be necessary if e‐cigarettes are to compete successfully with cigarettes to displace smoking and reduce risk [34, 35], and some harm reduction products have even been criticized for not having high enough abuse liability [36]. Thus, some continued dependence may be a favorable and even necessary trade‐off against the expected reduction in physical harm from e‐cigarettes.
A limitation of these analyses is that they are based on cross‐sectional data; analyses considering the trajectory of dependence over time would add to the picture presented here. As in any observational study, the smokers, e‐cigarette users, and dual users may differ in other ways that shaped their current use patterns; for example, those smokers who, for whatever reason, develop less dependence on e‐cigarettes may be less able to switch completely to vaping, and thus become dual users, while smokers who are more dependent might, in turn, have more difficulty switching completely to e‐cigarettes. As cigarettes have been available for much longer than e‐cigarettes, duration of use is a confounding factor; it is possible that e‐cigarette dependence could increase over time as users accumulate years of use. The analyses did not address dependence on particular kinds of e‐cigarettes or e‐liquids, which may differ in their effectiveness at delivering nicotine; subsequent analyses should consider how these variations affect dependence. Another limitation, deriving from PATH's design, is that a cigarette dependence measure was available only for those smokers who did not also use another (non‐e‐cigarette) tobacco product, which excluded one of five smokers, who might plausibly differ in dependence. However, among e‐cigarette users, we were able to contrast ‘pure’ e‐cigarette users with those also using other tobacco products, and saw only small differences, with both groups showing lower dependence than did ‘pure’ cigarette smokers. Findings about residual dependence in former smokers and e‐cigarette users should be considered with caution, as this assessment was not validated in the Strong et al. [21] PATH analyses. These data also address only adult smokers and e‐cigarette users, whereas there is considerable interest in the experience of youth who smoke and/or use e‐cigarettes. Finally, at the low end of the scale, the dependence scores were likely subject to floor effects; e.g., with former smokers and current non‐daily smokers scoring at dependence levels close to strong denial of dependence‐related experience, it may be difficult, both statistically and psychologically, to show further decreases.
Strengths of the analyses include the psychometric strengths of the IRT‐based PATH dependence scale, especially its statistically demonstrated ability to validly compare dependence across products. Other strengths include the large and nationally representative sample provided by the PATH survey, and the ability to do comparisons among diverse subsamples stratified by patterns of use.
In sum, multiple analyses showed that, whether they were using one or both products, users were less dependent on e‐cigarettes than on traditional combusted cigarettes. These findings were consistent with previous studies [5, 6], and suggest that e‐cigarettes may have less potential than conventional combusted cigarettes to produce dependence, suggesting that individuals who switch from smoking to e‐cigarettes may reduce their nicotine dependence as well as their health risks. This, in turn suggests that smokers who transition from cigarettes to e‐cigarettes may find it easier to subsequently transition off e‐cigarettes should they try to do so. Further research is needed on the trajectories of use and dependence among e‐cigarette users.
Declaration of interests
At the time the analysis was conducted, Pinney Associates, Inc., provided consulting services on tobacco harm minimization (including smokeless tobacco and vapor products) to R.J. Reynolds Vapor Company, and RAI Services Company, all of which are subsidiaries of Reynolds American Inc. Currently, Pinney Associates, and both authors, consult to JUUL Labs, Inc. regarding e‐cigarettes and harm reduction. S.S. also owns an interest in intellectual property for a novel nicotine medication that has not been developed.
Supporting information
Acknowledgements
The authors are grateful to Matthew Carpenter (Medical University of South Carolina), Michael Dunbar (RAND Corporation), and Jack Henningfield (Pinney Associates and Johns Hopkins University) for comments on an earlier draft. The authors also are grateful for the contributions of Mimi Kim, PhD., an employee of RAIS, who helped convey the PATH team's protocol for analyzing dependence measures. This research was supported by RAI Services Company, which had no role in its conception, analysis, writing, or decision to submit for publication.
Author contributions
S.S. and M.A.S. had full access to all of the data in the study, which is available for public use, and take responsibility for the accuracy of the data analysis. S.S. conceptualized the project and wrote the majority of the manuscript. M.A.S. performed the data analysis and wrote portions of the manuscript.
Shiffman, S. , and Sembower, M. A. (2020) Dependence on e‐cigarettes and cigarettes in a cross‐sectional study of US adults. Addiction, 115: 1924–1931. 10.1111/add.15060.
Footnotes
The PATH study skip patterns precluded informative analysis of ‘experimenters’ who are using a product but have not achieved established use, because the items are administered only if individuals are experimenting with at least two products, and thus only to a highly selected and small subset.
References
- 1. Wang T. W., Asman K., Gentzke A. S., Cullen K. A., Holder‐Hayes E., Reyes‐Guzman C., et al Tobacco product use among adults ‐ United States, 2017. MMWR Morb Mortal Wkly Rep 2018; 67: 1225–1232. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. National Academies of Sciences Engineering and Medicine Public Health Consequences of E‐Cigarettes. Washington, DC: The National Academies Press; 2018. [PubMed] [Google Scholar]
- 3. Mcneill A., Brose L. S., Calder R., Bauld L., Robson D. A report commissioned by Public Health England. London: Public Health England; 2018. [Google Scholar]
- 4. Avdalovic M. V., Murin S. POINT: does the risk of electronic cigarettes exceed potential benefits? Yes, Chest 2015; 148: 580–582. [DOI] [PubMed] [Google Scholar]
- 5. Etter J. F., Eissenberg T. Dependence levels in users of electronic cigarettes, nicotine gums and tobacco cigarettes. Drug Alcohol Depend 2015; 147: 68–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Farsalinos K. E., Romagna G., Tsiapras D., Kyrzopoulos S., Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst Abuse: Res Treatment 2013; 7: 139–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Jankowski M., Krzystanek M., Zejda J. E., Majek P., Lubanski J., Lawson J. A., et al E‐cigarettes are more addictive than traditional cigarettes‐a study in highly educated young people. Int J Environ Res Public Health 2019; 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Morean M., Krishnan‐Sarin S., O'malley S. S. Comparing cigarette and e‐cigarette dependence and predicting frequency of smoking and e‐cigarette use in dual‐users of cigarettes and e‐cigarettes. Addict Behav 2018; 87: 92–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Smith S. S., Piper M. E., Bolt D. M., Fiore M. C., Wetter D. W., Cinciripini P. M., et al Development of the brief Wisconsin inventory of smoking dependence motives. Nicotine Tob Res 2010; 12: 489–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Shiffman S., Waters A., Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res 2004; 6: 327–348. [DOI] [PubMed] [Google Scholar]
- 11. Sterling K. L., Mermelstein R., Turner L., Diviak K., Flay B., Shiffman S. Examining the psychometric properties and predictive validity of a youth‐specific version of the nicotine dependence syndrome scale (NDSS) among teens with varying levels of smoking. Addict Behav 2009; 34: 616–619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Piper M. E., Baker T. B., Benowitz N. L., Smith S. S., Jorenby D. E. E‐cigarette dependence measures in dual users: reliability and relations with dependence criteria and E‐cigarette cessation. Nicotine Tob Res 2019. https://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntz040/5381490 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Piper M. E., Bolt D. M., Kim S. Y., Japuntich S. J., Smith S. S., Niederdeppe J., et al Refining the tobacco dependence phenotype using the Wisconsin inventory of smoking dependence motives. J Abnorm Psychol 2008; 117: 747–761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Piper M. E., Mccarthy D. E., Bolt D. M., Smith S. S., Lerman C., Benowitz N., et al Assessing dimensions of nicotine dependence: an evaluation of the nicotine dependence syndrome scale (NDSS) and the Wisconsin inventory of smoking dependence motives (WISDM). Nicotine Tob Res 2008; 10: 1009–1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Adkison S. E., Rees V. W., Bansal‐Travers M., Hatsukami D. K., O'connor R. J. Psychometric characteristics of the brief Wisconsin inventory of smoking dependence motives among a nonclinical sample of smokers. Nicotine Tob Res 2016; 18: 470–476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Japuntich S. J., Piper M. E., Schlam T. R., Bolt D. M., Baker T. B. Do smokers know what we're talking about? The construct validity of nicotine dependence questionnaire measures. Psychol Assess 2009; 21: 595–607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Piasecki T. M., Piper M. E., Baker T. B. Refining the tobacco dependence phenotype using the Wisconsin inventory of smoking dependence motives: II. Evidence from a laboratory self‐administration assay. J Abnorm Psychol 2010; 119: 513–523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. American Psychiatric Association., American Psychiatric Association Dsm‐5 Task Force. Diagnostic and statistical manual of mental disorders: DSM‐5. Washington, D.C.: American Psychiatric Association; 2013. [Google Scholar]
- 19. Baker T. B., Breslau N., Covey L., Shiffman S. DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM‐5. Addiction 2012; 107: 263–275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Pomerleau C. S., Carton S. M., Lutzke M. L., Flessland K. A., Pomerleau O. F. Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence. Addict Behav 1994; 19: 33–39. [DOI] [PubMed] [Google Scholar]
- 21. Strong D. R., Pearson J., Ehlke S., Kirchner T., Abrams D., Taylor K., et al Indicators of dependence for different types of tobacco product users: descriptive findings from wave 1 (2013‐2014) of the population assessment of tobacco and health (PATH) study. Drug Alcohol Depend 2017; 178: 257–266. [DOI] [PubMed] [Google Scholar]
- 22. Embretson S. E., Reise S. P. Item response theory for psychologists. Mahwah, N.J.: Lawrence Erlbaum Associates; 2000. [Google Scholar]
- 23. Truth Initiative . E‐cigarettes: Facts, stats and regulations. 2019. Available at https://truthinitiative.org/research‐resources/emerging‐tobacco‐products/e‐cigarettes‐facts‐stats‐and‐regulations.
- 24. Manzoli L., Flacco M. E., Ferrante M., La Vecchia C., Siliquini R., Ricciardi W., et al Cohort study of electronic cigarette use: effectiveness and safety at 24 months. Tob Control 2017; 26: 284–292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Hyland A., Ambrose B. K., Conway K. P., Borek N., Lambert E., Carusi C., et al Design and methods of the population assessment of tobacco and health (PATH) study. Tob Control 2017; 26: 371–378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. United States Department of Health and Human Services; National Institutes of Health; National Institute on Drug Abuse; Food and Drug Administration; Center for Tobacco Products. Population Assessment of Tobacco and Health (PATH) Study [United States] Public‐Use Files. Ann Arbor, MI: Inter‐university Consortium for Political and Social Research [distributor], 2018‐09‐28; 10.3886/ICPSR36498.v8, 2018. [DOI] [Google Scholar]
- 27. United States Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Food and Drug Administration, Center for Tobacco Products . Population Assessment of Tobacco and Health (PATH) Study [United States] Public‐Use Files: Inter‐university Consortium for Political and Social Research [distributor]; 2018. [Google Scholar]
- 28. Breslau N., Johnson E. O., Hiripi E., Kessler R. Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Arch Gen Psychiatry 2001; 58: 810–816. [DOI] [PubMed] [Google Scholar]
- 29. Liu G., Wasserman E., Kong L., Foulds J. A comparison of nicotine dependence among exclusive E‐cigarette and cigarette users in the PATH study. Prev Med 2017; 104: 86–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Biener L., Hargraves J. L. A longitudinal study of electronic cigarette use among a population‐based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res 2015; 17: 127–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Levy D. T., Yuan Z., Luo Y., Abrams D. B. The relationship of E‐cigarette use to cigarette quit attempts and cessation: insights from a large, nationally representative U.S. survey. Nicotine Tob Res 2018; 20: 931–939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Gottlieb S., Zeller M. A nicotine‐focused framework for public health. N Engl J Med 2017; 377: 1111–1114. [DOI] [PubMed] [Google Scholar]
- 33. Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP, 2016, 2016. [Google Scholar]
- 34. Abrams D. B., Glasser A. M., Pearson J. L., Villanti A. C., Collins L. K., Niaura R. S. Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives. Annu Rev Public Health 2018; 39: 193–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Britton J., Arnott D., Mcneill A., Hopkinson N. Tobacco advisory Group of the Royal College of P. nicotine without smoke‐putting electronic cigarettes in context. BMJ 2016; 353: i1745. [DOI] [PubMed] [Google Scholar]
- 36. Food and Drug Administration . FDA Briefing Document. September 13–14, 2018 Meeting of the Tobacco Products Scientific Advisory Committee (TPSAC). Modified Risk Tobacco Product Applications (MRPTAs) MR0000068‐MR0000073 RJ Reynolds Tobacco Company. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCommittee/UCM620064.pdf. Accessed June 26, 2019.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.